Package 0187-0004-02

{"route": ["SUBCUTANEOUS"], "spl_id": "c9a0dc71-df40-4d05-8ba8-33bfdc068a5d", "openfda": {"nui": ["N0000193276", "N0000193279", "M0001357"], "unii": ["6ZA31Y954Z"], "rxcui": ["1872256", "1872261"], "spl_set_id": ["1a550c33-456a-4833-814e-8591aea7c688"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Interleukin-17 Receptor A Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 17 Receptor A Antagonists [MoA]"], "manufacturer_name": ["Bausch Health US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (0187-0004-02)  / 1 INJECTION in 1 SYRINGE (0187-0004-00)", "package_ndc": "0187-0004-02", "marketing_start_date": "20170215"}], "brand_name": "Siliq", "product_id": "0187-0004_c9a0dc71-df40-4d05-8ba8-33bfdc068a5d", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Interleukin 17 Receptor A Antagonists [MoA]", "Interleukin-17 Receptor A Antagonist [EPC]"], "product_ndc": "0187-0004", "generic_name": "Brodalumab", "labeler_name": "Bausch Health US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Siliq", "active_ingredients": [{"name": "BRODALUMAB", "strength": "210 mg/1"}], "application_number": "BLA761032", "marketing_category": "BLA", "marketing_start_date": "20170215", "listing_expiration_date": "20271231"}